182 related articles for article (PubMed ID: 38384328)
21. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer.
Duan X; Yang L; Wang L; Liu Q; Zhang K; Liu S; Liu C; Gao Q; Li L; Qin G; Zhang Y
Cell Biosci; 2022 May; 12(1):60. PubMed ID: 35568876
[TBL] [Abstract][Full Text] [Related]
22. GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2/QKI axis in breast cancer.
Yan Y; Ma J; Chen Q; Zhang T; Fan R; Du J
Discov Oncol; 2024 May; 15(1):182. PubMed ID: 38782769
[TBL] [Abstract][Full Text] [Related]
23. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
24. m6A demethylase FTO and osteoporosis: potential therapeutic interventions.
Huang M; Guo J; Liu L; Jin H; Chen X; Zou J
Front Cell Dev Biol; 2023; 11():1275475. PubMed ID: 38020896
[TBL] [Abstract][Full Text] [Related]
25. The FTO m
Zhu K; Li Y; Xu Y
Life Sci; 2021 Apr; 271():119180. PubMed ID: 33571513
[TBL] [Abstract][Full Text] [Related]
26. Fat mass and obesity-associated protein promotes the tumorigenesis and development of liver cancer.
Ye Z; Wang S; Chen W; Zhang X; Chen J; Jiang J; Wang M; Zhang L; Xuan Z
Oncol Lett; 2020 Aug; 20(2):1409-1417. PubMed ID: 32724383
[TBL] [Abstract][Full Text] [Related]
27. The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers.
Wang JY; Chen LJ; Qiang P
Onco Targets Ther; 2020; 13():12845-12856. PubMed ID: 33364780
[TBL] [Abstract][Full Text] [Related]
28. The m
Li X; Li Y; Wang Y; He X
Cytokine; 2022 Nov; 159():156000. PubMed ID: 36058192
[TBL] [Abstract][Full Text] [Related]
29. N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion.
Xie D; Yang K; Xu Y; Li Y; Liu C; Dong Y; Chi J; Yin X
J Diabetes Complications; 2024 Jun; 38(8):108801. PubMed ID: 38935979
[TBL] [Abstract][Full Text] [Related]
30. Phenethyl isothiocyanate inhibits metastasis potential of non-small cell lung cancer cells through FTO mediated TLE1 m
Zhang QC; Qian YM; Ren YH; Chen MM; Cao LM; Zheng SJ; Li BB; Wang M; Wu X; Xu K
Acta Pharmacol Sin; 2024 Mar; 45(3):619-632. PubMed ID: 37848553
[TBL] [Abstract][Full Text] [Related]
31. Increased N6-methyladenosine causes infertility is associated with FTO expression.
Ding C; Zou Q; Ding J; Ling M; Wang W; Li H; Huang B
J Cell Physiol; 2018 Sep; 233(9):7055-7066. PubMed ID: 29384212
[TBL] [Abstract][Full Text] [Related]
32. The m6A demethylase FTO promotes keloid formation by up-regulating COL1A1.
Ren S; Ji Y; Wang M; Ye M; Huang L; Cai X
Ann Transl Med; 2023 Jan; 11(1):15. PubMed ID: 36760238
[TBL] [Abstract][Full Text] [Related]
33. FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc.
Wang A; Jin C; Wang Y; Yu J; Wang R; Tian X
Mol Carcinog; 2023 Aug; 62(8):1228-1237. PubMed ID: 37306026
[TBL] [Abstract][Full Text] [Related]
34. Demethylase FTO-mediated m6A modification of SIK1 modulates placental cytotrophoblast syncytialization in type 2 diabetes mellitus.
Ning J; Yan J; Wang S; Cui Z; Xue Y; Juan J; Yang H
iScience; 2024 Jun; 27(6):109900. PubMed ID: 38883837
[TBL] [Abstract][Full Text] [Related]
35. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
[TBL] [Abstract][Full Text] [Related]
36. Targeting FTO Suppresses Pancreatic Carcinogenesis via Regulating Stem Cell Maintenance and EMT Pathway.
Garg R; Melstrom L; Chen J; He C; Goel A
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497402
[TBL] [Abstract][Full Text] [Related]
37. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
38. Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
Shan HJ; Gu WX; Duan G; Chen HL
Bioengineered; 2022 Apr; 13(4):8038-8050. PubMed ID: 35311620
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
Song W; Yang K; Luo J; Gao Z; Gao Y
Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
[TBL] [Abstract][Full Text] [Related]
40. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
